Company
Vytora Health
Vytora Health publishes compounded semaglutide, compounded tirzepatide and brand tirzepatide, from $179 to $1,399 a month.
- 3 programs
- 3 molecules
- 3 readings
Read from vytorahealth.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to Vytora Health
We earn nothing from this link. Vytora Health has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Top pricing card, monthly
first month, including the required fees on record · Top pricing card, monthly
first month, including the required fees on record · Mounjaro, month-to-month
Terms
| States | All 50 states |
|---|
Not yet checked: pharmacy, membership and consultation fee.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. The homepage publishes two different prices for the identical product in two places on the same page visit: the top pricing card lists Compounded Tirzepatide at '$249/month, billed monthly,' while the FAQ pricing table for the same product says '1-month: $199/mo · 3-month: $199/mo.' Compounded Semaglutide has a smaller but real gap too ($179 vs. $149 for a 3-month plan). Both figures are recorded rather than resolved by guessing which is authoritative. Mounjaro (labeled 'for type 2 diabetes') and Zepbound (labeled for weight loss) are both sold at the identical $1,399/month brand-tirzepatide retail price.
Before you act
Cite this
Treatment Registry. (2026). Vytora Health: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/vytora-health